Gilead to discount its pricey Sovaldi drug By: MarketWatch February 04, 2015 at 13:04 PM EST Gilead Sciences Inc. is expected to discount its pricey Sovaldi drug by as much as 46%. Read More >> Related Stocks: AbbVie Gilead Sciences Merck & Co